AMEDISYS INC - Common Stock, par value $0.001 per share (AMED)

Historical Holders from Q1 2014 to Q3 2025

Symbol
AMED
CUSIP
023436108
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
33M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
510
Holdings value
$50.3K
% of all portfolios
0%
Grand Portfolio weight change
-0.005%
Number of holders
3
Number of buys
1
Number of sells
-309
Average Value change %
-0.01%
Average buys %
+0%
Average sells %
-0.01%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of AMEDISYS INC - Common Stock, par value $0.001 per share (AMED)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GOLDMAN SACHS GROUP INC 0% -108% $19.2K -$179M 190 -100% THE GOLDMAN SACHS GROUP, INC. Sep 30, 2025

Institutional Holders of AMEDISYS INC - Common Stock, par value $0.001 per share (AMED)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 510 $50.3K -$3.24B $98.60 3
2025 Q2 33M $3.25B +$158M $98.39 318
2025 Q1 28.8M $2.67B -$40.7M $92.63 298
2024 Q4 29.1M $2.64B +$16.5M $90.79 285
2024 Q3 28M $2.7B -$154M $96.51 279
2024 Q2 29.5M $2.71B +$42.6M $91.80 281
2024 Q1 29.2M $2.69B -$146M $92.16 282
2023 Q4 746K $70.9M +$44.9M $95.06 5
2023 Q3 29M $2.71B -$77.8M $93.40 277
2023 Q2 29.8M $2.72B -$86.8M $91.44 291
2023 Q1 31.2M $2.3B +$6.54M $73.55 272
2022 Q4 30.5M $2.55B -$50.2M $83.54 264
2022 Q3 27.1M $2.62B +$117M $96.79 256
2022 Q2 25.1M $2.64B -$56M $105.12 263
2022 Q1 29.8M $5.14B +$164M $172.29 310
2021 Q4 29.2M $4.72B +$73.9M $161.88 308
2021 Q3 28.3M $4.22B -$208M $149.10 342
2021 Q2 28.9M $7.09B +$85.1M $244.93 362
2021 Q1 28.5M $7.55B -$67.7M $264.79 382
2020 Q4 29.1M $8.53B +$83.8M $293.33 390
2020 Q3 28.5M $6.73B -$177M $236.43 378
2020 Q2 29.3M $5.81B +$152M $198.54 339
2020 Q1 28.5M $5.23B -$2.95M $183.54 317
2019 Q4 29M $4.84B -$102M $166.92 318
2019 Q3 29.8M $3.9B +$122M $131.01 277
2019 Q2 29M $3.51B +$211M $121.41 279
2019 Q1 28M $3.44B -$139M $123.26 310
2018 Q4 24.4M $2.85B -$105M $117.11 292
2018 Q3 30M $3.74B -$36.2M $124.96 261
2018 Q2 30.5M $2.6B -$129M $85.46 211
2018 Q1 32.6M $1.97B +$25.1M $60.34 190
2017 Q4 32.7M $1.73B +$22.3M $52.71 181
2017 Q3 32.4M $1.82B -$51.7M $55.96 160
2017 Q2 33M $2.07B -$8.49M $62.81 168
2017 Q1 32.4M $1.65B +$285M $51.09 149
2016 Q4 32.4M $1.38B +$33.6M $42.63 155
2016 Q3 31.7M $1.5B +$69.1M $47.44 152
2016 Q2 31M $1.56B +$28.4M $50.48 164
2016 Q1 29.3M $1.42B +$18.8M $48.34 165
2015 Q4 30.1M $1.19B -$2.25M $39.32 162
2015 Q3 30.2M $1.15B +$29.4M $37.97 172
2015 Q2 28.7M $1.14B +$46.2M $39.73 142
2015 Q1 27.9M $748M -$9.83M $26.78 127
2014 Q4 28.7M $843M -$23.2M $29.35 138
2014 Q3 30M $604M -$6.82M $20.17 123
2014 Q2 30.5M $510M +$4.36M $16.74 122
2014 Q1 28.8M $430M +$15.1M $14.89 115